- Latest Posts
Best in Biotech 26 Jun 2023
Five animal health companies you should know about
The animal health market initially emerged because of the demand for a specific segment within biotech and pharma that focuses on improving the life of animals, including companion animals, such as dogs and cats, and farm animals, such as cattle and poultry. Now, there are lots of animal health companies trying to make a difference […]
News and Trends 26 Jun 2023
AbbVie takes step forward in Europe with migraine drug
AbbVie says the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CMHP) has adopted a positive opinion recommending the approval of atogepant for the prophylaxis of migraine in adults who have four or more migraine days per month. If approved, AbbVie will be the only company to offer a once daily oral […]
Best in Biotech 23 Jun 2023
Six biotech companies in South Korea you should know about
A major player in the machinery, electronics and telecommunications market, South Korea’s growing biotech industry has made headlines over the past few years. Home to hundreds of biopharmaceutical companies, the sector saw ₩2.8 trillion ($2.14 billion) worth of investments pour in, according to 2021 statistics. One of the largest contract drug developers, Samsung Biologics, headquartered […]
News and Trends 23 Jun 2023
New disease characteristic seen as NMD Pharma reports Charcot-Marie-Tooth results
NMD Pharma A/S, a clinical stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for neuromuscular disorders, has presented results from ESTABLISH1, an observational study of neuromuscular function in patients with the inherited neurological conditions Charcot-Marie-Tooth (CMT) types 1 and 2. The results were revealed in a poster presentation at the Peripheral Nerve Society Annual […]
Podcast 23 Jun 2023
Beyond Biotech podcast 51
This week, we look at biomarkers, among other topics, with founder and CEO of Sapient, Mo Jain. We also have an overview of the Lund Spring Symposium with Dan Larhammar, Thoas Fioretos, and Sander van Deventer. Sapient Sapient is an end-to-end biomarker discovery organization dedicated to accelerating the mapping of circulating chemistries in humans through […]
ADVERTISEMENT
ADVERTISEMENT
News and Trends 23 Jun 2023
Breakthrough treatment for skin infections?
A research team led by Kelvin Yeung from the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has designed a new microneedle patch that provides an effective non-antibiotic approach for the treatment of skin infections. The design engineered with ultrasound-responsive zinc-based metal-organic framework (MOF) […]
News and Trends 23 Jun 2023
European Coalition for Access to Comprehensive Genomic Profiling launched
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) along with Exact Sciences, Guardant Health, Illumina, MSD and Novartis, have launched the European Coalition for Access to Comprehensive Genomic Profiling (ECGP), to improve cancer care through increased routine clinical access and reimbursement of Comprehensive Genomic Profiling (CGP) in Europe. CGP is a method of testing tumors that […]
News and Trends 23 Jun 2023
Sarepta gets approval for first gene therapy for Duchenne muscular dystrophy
Sarepta Therapeutics, Inc. has announced U.S. Food and Drug Administration (FDA) accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl), an Adeno-associated virus (AAV)-based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene. This indication is approved under accelerated approval […]
News and Trends 23 Jun 2023
SandboxAQ launches new division to boost drug development
After several years of stealth development, SandboxAQ has announced its bio-pharma molecular simulation division, AQBioSim, and some of its customers. The division is helping bio-pharma and research institutions achieve breakthroughs in treatments for cancer, Alzheimer’s, Parkinson’s, and other conditions. The company is currently working with biopharma companies and university research labs, including AstraZeneca, Sanofi and […]
News and Trends 22 Jun 2023
Alchemab Therapeutics unveils Alzheimer’s candidate
Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, has unveiled data on ATLX-1088, its newly-discovered preclinical Alzheimer’s candidate, at the Antibody Industrial Symposium in Tours, France. ATLX-1088 is a potential first-in-class human antibody targeting CD33, a cell surface protein thought to have a key role in Alzheimer’s disease. […]
News and Trends 22 Jun 2023
Ovarian cancer study finds key genes for potential treatments
New study is increasing knowledge of why some women with the most lethal form of ovarian cancer respond much better to treatment than others. Researchers at Imperial College London in the U.K. have confirmed that the tumors of some women with high-grade serious ovarian cancer (HGSOC) contain a type of lymphoid tissue – known as […]
ADVERTISEMENT
